Clinical Trial Update: A Study of LAD603 in Adults With Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LAD603 in adults with alopecia areata; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• LAD603

Snippet

Sponsor: Almirall, S.A. | Conditions: Alopecia Areata | Phase 2 | Status: RECRUITING